Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 15, 2024ChemistrySelect

Designing JAK2 Inhibitors Beyond Myeloproliferative Neoplasms ‐ Theoretical and Experimental Analysis for Solid Cancers

View Full Paper
Ask AI
Bookmark
Share

Authors

AAA. S. AchuthaSKSudhir KrishnaVPV.L. Pushpa

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Achutha et al. (2024) studied this question.

synapsesocial.com/papers/68e6a135b6db643587624ad2https://doi.org/10.1002/slct.202400072
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Molecular modeling of novel 2-aminopyridine derivatives as potential JAK2 inhibitors: a rational strategy for promising anticancer agents2024 · 6 citations
  2. 2High-throughput inhibitor screening and molecular dynamics simulation studies against Human JAK22025
  3. 3Discovery of JAK2V617F mutant specific allosteric inhibitors for the treatment of myeloproliferative neoplasms2025 · 2 citations
  4. 4Identification of novel, potent, and selective JAK2V617F inhibitors2025 · 1 citations
  5. 5New Binding Sites for JAK2 Inhibition in Myeloproliferative Neoplasms: Structural Insights, Therapeutic Potential, and Future Directions2026 · 1 citations